Changes in Hong Kong stocks | CRO concept stocks had the highest increase, Pharmaceutical Biotech (02269) rose more than 4%. Institutional indicators continue to verify that the performance of the sector is booming

Zhitongcaijing · 5d ago

The Zhitong Finance App learned that CRO concept stocks had the highest gains. As of press release, Gloria Ying (06821) rose 6.05% to HK$113.9; Pharmaceutical Biotech (02269) rose 4.27% to HK$44.9; Pharmaceutical Kangde (02359) rose 4.26% to HK$183.5; Kanglong Chemical (03759) rose 3.62% to HK$26.94.

According to the news, as the domestic third-quarter earnings season comes to an end, nearly 30 A-share CRO companies handed over performance questionnaires one after another: According to statistics from the Science and Technology Innovation Board Daily, after excluding companies with smaller market capitalization, almost all of the remaining 13 companies achieved a year-on-year increase in revenue and net profit to mother in a single quarter. Pharmaceutical Kangde, Kanglong Chemical, Gloria Ying, and Boteng Co., Ltd. all disclosed order growth expectations in their three-quarter reports. Furthermore, various companies actively followed the AI+ pharmaceutical narrative.

Guojin Securities pointed out that after the disclosure of the 2026 three-quarter report, Yao Ming Kangde continued to raise its performance guidelines for two consecutive quarters. On the one hand, the increase in performance guidelines reflects the continued execution of domestic and international orders for downstream innovative drugs, and on the other hand, it verifies the continuous consolidation of the upward logic of the CXO industry.